Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 12-1999 | 12-1998 | |
| Cash Flows From Operating Activities | |||
| Net Income | -18,280 | -25,190 | -20,940 |
| Depreciation Amortization | 3,020 | 3,480 | 3,340 |
| Other Working Capital | -4,490 | 1,950 | 710 |
| Other Operating Activity | 450 | 1,180 | 1,800 |
| Operating Cash Flow | $-19,300 | $-18,580 | $-15,090 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -50 | -30 | -70 |
| Other Investing Activity | -44,470 | -990 | -580 |
| Investing Cash Flow | $-44,520 | $-1,020 | $-650 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 78,130 | -1,610 | 58,490 |
| Financing Cash Flow | $78,130 | $-1,610 | $58,490 |
| Beginning Cash Position | 41,020 | 62,240 | 19,490 |
| End Cash Position | 55,330 | 41,020 | 62,240 |
| Net Cash Flow | $14,300 | $-21,220 | $42,740 |
| Free Cash Flow | |||
| Operating Cash Flow | -19,300 | -18,580 | -15,090 |
| Free Cash Flow | -19,300 | -18,580 | -15,090 |